Search

Your search keyword '"Ruiz, Agustín"' showing total 998 results

Search Constraints

Start Over You searched for: Author "Ruiz, Agustín" Remove constraint Author: "Ruiz, Agustín"
998 results on '"Ruiz, Agustín"'

Search Results

1. Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort

2. Identification of a specific APOE transcript and functional elements associated with Alzheimer’s disease

3. Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

4. Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort

5. Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort

6. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

8. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease

9. Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

10. Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia

11. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

12. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

13. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

14. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

15. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

18. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

19. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

20. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

21. Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease: A Double-Blind Masked Clinical Trial for Dose Finding

22. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

23. New insights into the genetic etiology of Alzheimer’s disease and related dementias

25. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

26. Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort

27. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

29. Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia

30. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.

32. FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants

33. Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer’s disease

34. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

35. Approaching allelic probabilities and Genome-Wide Association Studies from beta distributions

36. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

38. The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening

39. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

40. Frontotemporal dementia and its subtypes: a genome-wide association study

41. The first genome‐wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease

42. 1605 - EFICACIA Y SEGURIDAD DE BELIMUMAB EN LA COHORTE BELILES-GEAS

43. Identification of a specific APOE transcript and functional elements associated with Alzheimer’s disease

44. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations

45. Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

46. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

47. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

Catalog

Books, media, physical & digital resources